Greenlam Industries Ltd., which is among the top 3 laminate manufacturers in the world and largest in Asia, has announced that the company's in-house R&D team has developed a revolutionary product with antivirus attributes. Greenlam Laminates, with this new feature, will retard and kill up to 99.99% of viruses that come in contact with the surface. This has been tested and certified under Antiviral Efficacy Test as per ISO21702:2019 International Standard, by Biotech Testing Services (BTS) Mumbai.
Speaking on the occasion Mr. Saurabh Mittal, Managing Director and Chief Executive Officer, Greenlam Industries Ltd. said, "The entire world has been talking about different ways of maintaining hygiene both indoors and outdoors since the pandemic started. With a vision to help our customers build a safe environment, we are excited to announce that our laminates have been certified with antivirus attributes. This achievement is also a testament of our expertise and commitment to create best-in-class laminates. We would like to take this opportunity to thank our R&D team who relentlessly provide innovative technologies and creative solutions to our customers."
Greenlam Industries Ltd. has been producing laminates and compacts with antibacterial and antifungal attributes for several years. With this new certification Greenlam will now be able to offer laminates with triple health & hygiene features - AntiVirus, AntiBacterial and AntiFungal. The above attributes last throughout the life cycle of the entire range of Greenlam laminates. This reinforces the ability and agility of Greenlam Industries Ltd. to develop innovative products in sync with the market dynamics and customers' expectation.
Shares of Greenlam Industries Ltd was last trading in BSE at Rs.736 as compared to the previous close of Rs. 721.75. The total number of shares traded during the day was 172 in over 19 trades.
The stock hit an intraday high of Rs. 740 and intraday low of 733.3. The net turnover during the day was Rs. 126843.